NCT03367910View on ClinicalTrials.gov

Fecal Microbiota Transplantation (FMT) for MDRO UTI

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Urinary Tract Infections
Interventions
DRUG

Fecal microbiota transplant

150mL of FMT product RBX2660 delivered via enema

Trial Locations (1)

63110

Washington University, St Louis

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

University of Pennsylvania

OTHER

collaborator

Duke University

OTHER

collaborator

Rush University

OTHER

collaborator

Rebiotix Inc.

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT03367910 - Fecal Microbiota Transplantation (FMT) for MDRO UTI | Biotech Hunter | Biotech Hunter